Global At-Home Drug of Abuse (DOA) Testing Market Growth 2018-2023
The report requires updating with new data and is sent in 48 hours after order is placed.
The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.
The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.
According to this study, over the next five years the At-Home Drug of Abuse (DOA) Testing market will register a 8.7% CAGR in terms of revenue, the global market size will reach US$ 700 million by 2023, from US$ 430 million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in At-Home Drug of Abuse (DOA) Testing business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of At-Home Drug of Abuse (DOA) Testing market by product type, application, key manufacturers and key regions and countries.
This study considers the At-Home Drug of Abuse (DOA) Testing value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7.
RESEARCH OBJECTIVES
The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.
The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.
According to this study, over the next five years the At-Home Drug of Abuse (DOA) Testing market will register a 8.7% CAGR in terms of revenue, the global market size will reach US$ 700 million by 2023, from US$ 430 million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in At-Home Drug of Abuse (DOA) Testing business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of At-Home Drug of Abuse (DOA) Testing market by product type, application, key manufacturers and key regions and countries.
This study considers the At-Home Drug of Abuse (DOA) Testing value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7.
- Test Cups
- Test Dip Cards
- Test Strips
- Others
- Urine
- Saliva
- Hair
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- UCP Biosciences Inc.
- Orient New Life Medical Co. Ltd.
- Express Diagnostics Int’l Inc.
- Assure Tech (Hangzhou) Co. Ltd.
- Psychemedics Corporation
- Confirm BioSciences
- Phamatech Inc.
- Home Health (U.K.) Ltd.
- Quest Products Inc.
RESEARCH OBJECTIVES
- To study and analyze the global At-Home Drug of Abuse (DOA) Testing consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
- To understand the structure of At-Home Drug of Abuse (DOA) Testing market by identifying its various subsegments.
- Focuses on the key global At-Home Drug of Abuse (DOA) Testing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the At-Home Drug of Abuse (DOA) Testing with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of At-Home Drug of Abuse (DOA) Testing submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global At-Home Drug of Abuse (DOA) Testing Consumption 2013-2023
2.1.2 At-Home Drug of Abuse (DOA) Testing Consumption CAGR by Region
2.2 At-Home Drug of Abuse (DOA) Testing Segment by Type
2.2.1 Test Cups
2.2.2 Test Dip Cards
2.2.3 Test Strips
2.2.4 Others
2.3 At-Home Drug of Abuse (DOA) Testing Consumption by Type
2.3.1 Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type (2013-2018)
2.3.2 Global At-Home Drug of Abuse (DOA) Testing Revenue and Market Share by Type (2013-2018)
2.3.3 Global At-Home Drug of Abuse (DOA) Testing Sale Price by Type (2013-2018)
2.4 At-Home Drug of Abuse (DOA) Testing Segment by Application
2.4.1 Urine
2.4.2 Saliva
2.4.3 Hair
2.4.4 Others
2.5 At-Home Drug of Abuse (DOA) Testing Consumption by Application
2.5.1 Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application (2013-2018)
2.5.2 Global At-Home Drug of Abuse (DOA) Testing Value and Market Share by Application (2013-2018)
2.5.3 Global At-Home Drug of Abuse (DOA) Testing Sale Price by Application (2013-2018)
3 GLOBAL AT-HOME DRUG OF ABUSE (DOA) TESTING BY PLAYERS
3.1 Global At-Home Drug of Abuse (DOA) Testing Sales Market Share by Players
3.1.1 Global At-Home Drug of Abuse (DOA) Testing Sales by Players (2016-2018)
3.1.2 Global At-Home Drug of Abuse (DOA) Testing Sales Market Share by Players (2016-2018)
3.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players
3.2.1 Global At-Home Drug of Abuse (DOA) Testing Revenue by Players (2016-2018)
3.2.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players (2016-2018)
3.3 Global At-Home Drug of Abuse (DOA) Testing Sale Price by Players
3.4 Global At-Home Drug of Abuse (DOA) Testing Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global At-Home Drug of Abuse (DOA) Testing Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players At-Home Drug of Abuse (DOA) Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 AT-HOME DRUG OF ABUSE (DOA) TESTING BY REGIONS
4.1 At-Home Drug of Abuse (DOA) Testing by Regions
4.1.1 Global At-Home Drug of Abuse (DOA) Testing Consumption by Regions
4.1.2 Global At-Home Drug of Abuse (DOA) Testing Value by Regions
4.2 Americas At-Home Drug of Abuse (DOA) Testing Consumption Growth
4.3 APAC At-Home Drug of Abuse (DOA) Testing Consumption Growth
4.4 Europe At-Home Drug of Abuse (DOA) Testing Consumption Growth
4.5 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Growth
5 AMERICAS
5.1 Americas At-Home Drug of Abuse (DOA) Testing Consumption by Countries
5.1.1 Americas At-Home Drug of Abuse (DOA) Testing Consumption by Countries (2013-2018)
5.1.2 Americas At-Home Drug of Abuse (DOA) Testing Value by Countries (2013-2018)
5.2 Americas At-Home Drug of Abuse (DOA) Testing Consumption by Type
5.3 Americas At-Home Drug of Abuse (DOA) Testing Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC At-Home Drug of Abuse (DOA) Testing Consumption by Countries
6.1.1 APAC At-Home Drug of Abuse (DOA) Testing Consumption by Countries (2013-2018)
6.1.2 APAC At-Home Drug of Abuse (DOA) Testing Value by Countries (2013-2018)
6.2 APAC At-Home Drug of Abuse (DOA) Testing Consumption by Type
6.3 APAC At-Home Drug of Abuse (DOA) Testing Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe At-Home Drug of Abuse (DOA) Testing by Countries
7.1.1 Europe At-Home Drug of Abuse (DOA) Testing Consumption by Countries (2013-2018)
7.1.2 Europe At-Home Drug of Abuse (DOA) Testing Value by Countries (2013-2018)
7.2 Europe At-Home Drug of Abuse (DOA) Testing Consumption by Type
7.3 Europe At-Home Drug of Abuse (DOA) Testing Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing by Countries
8.1.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Value by Countries (2013-2018)
8.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption by Type
8.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 At-Home Drug of Abuse (DOA) Testing Distributors
10.3 At-Home Drug of Abuse (DOA) Testing Customer
11 GLOBAL AT-HOME DRUG OF ABUSE (DOA) TESTING MARKET FORECAST
11.1 Global At-Home Drug of Abuse (DOA) Testing Consumption Forecast (2018-2023)
11.2 Global At-Home Drug of Abuse (DOA) Testing Forecast by Regions
11.2.1 Global At-Home Drug of Abuse (DOA) Testing Forecast by Regions (2018-2023)
11.2.2 Global At-Home Drug of Abuse (DOA) Testing Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global At-Home Drug of Abuse (DOA) Testing Forecast by Type
11.8 Global At-Home Drug of Abuse (DOA) Testing Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 UCP Biosciences Inc.
12.1.1 Company Details
12.1.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.1.3 UCP Biosciences Inc. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 UCP Biosciences Inc. News
12.2 Orient New Life Medical Co. Ltd.
12.2.1 Company Details
12.2.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.2.3 Orient New Life Medical Co. Ltd. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Orient New Life Medical Co. Ltd. News
12.3 Express Diagnostics Int’l Inc.
12.3.1 Company Details
12.3.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.3.3 Express Diagnostics Int’l Inc. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Express Diagnostics Int’l Inc. News
12.4 Assure Tech (Hangzhou) Co. Ltd.
12.4.1 Company Details
12.4.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.4.3 Assure Tech (Hangzhou) Co. Ltd. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Assure Tech (Hangzhou) Co. Ltd. News
12.5 Psychemedics Corporation
12.5.1 Company Details
12.5.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Psychemedics Corporation News
12.6 Confirm BioSciences
12.6.1 Company Details
12.6.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Confirm BioSciences News
12.7 Phamatech Inc.
12.7.1 Company Details
12.7.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.7.3 Phamatech Inc. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Phamatech Inc. News
12.8 Home Health (U.K.) Ltd.
12.8.1 Company Details
12.8.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Home Health (U.K.) Ltd. News
12.9 Quest Products Inc.
12.9.1 Company Details
12.9.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.9.3 Quest Products Inc. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Quest Products Inc. News
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global At-Home Drug of Abuse (DOA) Testing Consumption 2013-2023
2.1.2 At-Home Drug of Abuse (DOA) Testing Consumption CAGR by Region
2.2 At-Home Drug of Abuse (DOA) Testing Segment by Type
2.2.1 Test Cups
2.2.2 Test Dip Cards
2.2.3 Test Strips
2.2.4 Others
2.3 At-Home Drug of Abuse (DOA) Testing Consumption by Type
2.3.1 Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type (2013-2018)
2.3.2 Global At-Home Drug of Abuse (DOA) Testing Revenue and Market Share by Type (2013-2018)
2.3.3 Global At-Home Drug of Abuse (DOA) Testing Sale Price by Type (2013-2018)
2.4 At-Home Drug of Abuse (DOA) Testing Segment by Application
2.4.1 Urine
2.4.2 Saliva
2.4.3 Hair
2.4.4 Others
2.5 At-Home Drug of Abuse (DOA) Testing Consumption by Application
2.5.1 Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application (2013-2018)
2.5.2 Global At-Home Drug of Abuse (DOA) Testing Value and Market Share by Application (2013-2018)
2.5.3 Global At-Home Drug of Abuse (DOA) Testing Sale Price by Application (2013-2018)
3 GLOBAL AT-HOME DRUG OF ABUSE (DOA) TESTING BY PLAYERS
3.1 Global At-Home Drug of Abuse (DOA) Testing Sales Market Share by Players
3.1.1 Global At-Home Drug of Abuse (DOA) Testing Sales by Players (2016-2018)
3.1.2 Global At-Home Drug of Abuse (DOA) Testing Sales Market Share by Players (2016-2018)
3.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players
3.2.1 Global At-Home Drug of Abuse (DOA) Testing Revenue by Players (2016-2018)
3.2.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players (2016-2018)
3.3 Global At-Home Drug of Abuse (DOA) Testing Sale Price by Players
3.4 Global At-Home Drug of Abuse (DOA) Testing Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global At-Home Drug of Abuse (DOA) Testing Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players At-Home Drug of Abuse (DOA) Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 AT-HOME DRUG OF ABUSE (DOA) TESTING BY REGIONS
4.1 At-Home Drug of Abuse (DOA) Testing by Regions
4.1.1 Global At-Home Drug of Abuse (DOA) Testing Consumption by Regions
4.1.2 Global At-Home Drug of Abuse (DOA) Testing Value by Regions
4.2 Americas At-Home Drug of Abuse (DOA) Testing Consumption Growth
4.3 APAC At-Home Drug of Abuse (DOA) Testing Consumption Growth
4.4 Europe At-Home Drug of Abuse (DOA) Testing Consumption Growth
4.5 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Growth
5 AMERICAS
5.1 Americas At-Home Drug of Abuse (DOA) Testing Consumption by Countries
5.1.1 Americas At-Home Drug of Abuse (DOA) Testing Consumption by Countries (2013-2018)
5.1.2 Americas At-Home Drug of Abuse (DOA) Testing Value by Countries (2013-2018)
5.2 Americas At-Home Drug of Abuse (DOA) Testing Consumption by Type
5.3 Americas At-Home Drug of Abuse (DOA) Testing Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC At-Home Drug of Abuse (DOA) Testing Consumption by Countries
6.1.1 APAC At-Home Drug of Abuse (DOA) Testing Consumption by Countries (2013-2018)
6.1.2 APAC At-Home Drug of Abuse (DOA) Testing Value by Countries (2013-2018)
6.2 APAC At-Home Drug of Abuse (DOA) Testing Consumption by Type
6.3 APAC At-Home Drug of Abuse (DOA) Testing Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe At-Home Drug of Abuse (DOA) Testing by Countries
7.1.1 Europe At-Home Drug of Abuse (DOA) Testing Consumption by Countries (2013-2018)
7.1.2 Europe At-Home Drug of Abuse (DOA) Testing Value by Countries (2013-2018)
7.2 Europe At-Home Drug of Abuse (DOA) Testing Consumption by Type
7.3 Europe At-Home Drug of Abuse (DOA) Testing Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing by Countries
8.1.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Value by Countries (2013-2018)
8.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption by Type
8.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 At-Home Drug of Abuse (DOA) Testing Distributors
10.3 At-Home Drug of Abuse (DOA) Testing Customer
11 GLOBAL AT-HOME DRUG OF ABUSE (DOA) TESTING MARKET FORECAST
11.1 Global At-Home Drug of Abuse (DOA) Testing Consumption Forecast (2018-2023)
11.2 Global At-Home Drug of Abuse (DOA) Testing Forecast by Regions
11.2.1 Global At-Home Drug of Abuse (DOA) Testing Forecast by Regions (2018-2023)
11.2.2 Global At-Home Drug of Abuse (DOA) Testing Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global At-Home Drug of Abuse (DOA) Testing Forecast by Type
11.8 Global At-Home Drug of Abuse (DOA) Testing Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 UCP Biosciences Inc.
12.1.1 Company Details
12.1.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.1.3 UCP Biosciences Inc. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 UCP Biosciences Inc. News
12.2 Orient New Life Medical Co. Ltd.
12.2.1 Company Details
12.2.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.2.3 Orient New Life Medical Co. Ltd. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Orient New Life Medical Co. Ltd. News
12.3 Express Diagnostics Int’l Inc.
12.3.1 Company Details
12.3.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.3.3 Express Diagnostics Int’l Inc. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Express Diagnostics Int’l Inc. News
12.4 Assure Tech (Hangzhou) Co. Ltd.
12.4.1 Company Details
12.4.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.4.3 Assure Tech (Hangzhou) Co. Ltd. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Assure Tech (Hangzhou) Co. Ltd. News
12.5 Psychemedics Corporation
12.5.1 Company Details
12.5.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Psychemedics Corporation News
12.6 Confirm BioSciences
12.6.1 Company Details
12.6.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Confirm BioSciences News
12.7 Phamatech Inc.
12.7.1 Company Details
12.7.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.7.3 Phamatech Inc. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Phamatech Inc. News
12.8 Home Health (U.K.) Ltd.
12.8.1 Company Details
12.8.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Home Health (U.K.) Ltd. News
12.9 Quest Products Inc.
12.9.1 Company Details
12.9.2 At-Home Drug of Abuse (DOA) Testing Product Offered
12.9.3 Quest Products Inc. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Quest Products Inc. News
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Figure Picture of At-Home Drug of Abuse (DOA) Testing
Table Product Specifications of At-Home Drug of Abuse (DOA) Testing
Figure At-Home Drug of Abuse (DOA) Testing Report Years Considered
Figure Market Research Methodology
Figure Global At-Home Drug of Abuse (DOA) Testing Consumption Growth Rate 2013-2023 (K Units)
Figure Global At-Home Drug of Abuse (DOA) Testing Value Growth Rate 2013-2023 ($ Millions)
Table At-Home Drug of Abuse (DOA) Testing Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Test Cups
Table Major Players of Test Cups
Figure Product Picture of Test Dip Cards
Table Major Players of Test Dip Cards
Figure Product Picture of Test Strips
Table Major Players of Test Strips
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2013-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type (2013-2018)
Figure Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type (2013-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Revenue by Type (2013-2018) ($ million)
Table Global At-Home Drug of Abuse (DOA) Testing Value Market Share by Type (2013-2018) ($ Millions)
Figure Global At-Home Drug of Abuse (DOA) Testing Value Market Share by Type (2013-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Sale Price by Type (2013-2018)
Figure At-Home Drug of Abuse (DOA) Testing Consumed in Urine
Figure Global At-Home Drug of Abuse (DOA) Testing Market: Urine (2013-2018) (K Units)
Figure Global At-Home Drug of Abuse (DOA) Testing Market: Urine (2013-2018) ($ Millions)
Figure Global Urine YoY Growth ($ Millions)
Figure At-Home Drug of Abuse (DOA) Testing Consumed in Saliva
Figure Global At-Home Drug of Abuse (DOA) Testing Market: Saliva (2013-2018) (K Units)
Figure Global At-Home Drug of Abuse (DOA) Testing Market: Saliva (2013-2018) ($ Millions)
Figure Global Saliva YoY Growth ($ Millions)
Figure At-Home Drug of Abuse (DOA) Testing Consumed in Hair
Figure Global At-Home Drug of Abuse (DOA) Testing Market: Hair (2013-2018) (K Units)
Figure Global At-Home Drug of Abuse (DOA) Testing Market: Hair (2013-2018) ($ Millions)
Figure Global Hair YoY Growth ($ Millions)
Figure At-Home Drug of Abuse (DOA) Testing Consumed in Others
Figure Global At-Home Drug of Abuse (DOA) Testing Market: Others (2013-2018) (K Units)
Figure Global At-Home Drug of Abuse (DOA) Testing Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application (2013-2018)
Figure Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application (2013-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Value by Application (2013-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Value Market Share by Application (2013-2018)
Figure Global At-Home Drug of Abuse (DOA) Testing Value Market Share by Application (2013-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Sale Price by Application (2013-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Sales by Players (2016-2018) (K Units)
Table Global At-Home Drug of Abuse (DOA) Testing Sales Market Share by Players (2016-2018)
Figure Global At-Home Drug of Abuse (DOA) Testing Sales Market Share by Players in 2016
Figure Global At-Home Drug of Abuse (DOA) Testing Sales Market Share by Players in 2017
Table Global At-Home Drug of Abuse (DOA) Testing Revenue by Players (2016-2018) ($ Millions)
Table Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players (2016-2018)
Figure Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players in 2016
Figure Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players in 2017
Table Global At-Home Drug of Abuse (DOA) Testing Sale Price by Players (2016-2018)
Figure Global At-Home Drug of Abuse (DOA) Testing Sale Price by Players in 2017
Table Global At-Home Drug of Abuse (DOA) Testing Manufacturing Base Distribution and Sales Area by Players
Table Players At-Home Drug of Abuse (DOA) Testing Products Offered
Table At-Home Drug of Abuse (DOA) Testing Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption by Regions 2013-2018 (K Units)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Regions 2013-2018
Figure Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Regions 2013-2018
Table Global At-Home Drug of Abuse (DOA) Testing Value by Regions 2013-2018 ($ Millions)
Table Global At-Home Drug of Abuse (DOA) Testing Value Market Share by Regions 2013-2018
Figure Global At-Home Drug of Abuse (DOA) Testing Value Market Share by Regions 2013-2018
Figure Americas At-Home Drug of Abuse (DOA) Testing Consumption 2013-2018 (K Units)
Figure Americas At-Home Drug of Abuse (DOA) Testing Value 2013-2018 ($ Millions)
Figure APAC At-Home Drug of Abuse (DOA) Testing Consumption 2013-2018 (K Units)
Figure APAC At-Home Drug of Abuse (DOA) Testing Value 2013-2018 ($ Millions)
Figure Europe At-Home Drug of Abuse (DOA) Testing Consumption 2013-2018 (K Units)
Figure Europe At-Home Drug of Abuse (DOA) Testing Value 2013-2018 ($ Millions)
Figure Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption 2013-2018 (K Units)
Figure Middle East & Africa At-Home Drug of Abuse (DOA) Testing Value 2013-2018 ($ Millions)
Table Americas At-Home Drug of Abuse (DOA) Testing Consumption by Countries (2013-2018) (K Units)
Table Americas At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Countries (2013-2018)
Figure Americas At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Countries in 2017
Table Americas At-Home Drug of Abuse (DOA) Testing Value by Countries (2013-2018) ($ Millions)
Table Americas At-Home Drug of Abuse (DOA) Testing Value Market Share by Countries (2013-2018)
Figure Americas At-Home Drug of Abuse (DOA) Testing Value Market Share by Countries in 2017
Table Americas At-Home Drug of Abuse (DOA) Testing Consumption by Type (2013-2018) (K Units)
Table Americas At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type (2013-2018)
Figure Americas At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type in 2017
Table Americas At-Home Drug of Abuse (DOA) Testing Consumption by Application (2013-2018) (K Units)
Table Americas At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application (2013-2018)
Figure Americas At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application in 2017
Figure United States At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure United States At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Canada At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Canada At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Mexico At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Mexico At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Table APAC At-Home Drug of Abuse (DOA) Testing Consumption by Countries (2013-2018) (K Units)
Table APAC At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Countries (2013-2018)
Figure APAC At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Countries in 2017
Table APAC At-Home Drug of Abuse (DOA) Testing Value by Countries (2013-2018) ($ Millions)
Table APAC At-Home Drug of Abuse (DOA) Testing Value Market Share by Countries (2013-2018)
Figure APAC At-Home Drug of Abuse (DOA) Testing Value Market Share by Countries in 2017
Table APAC At-Home Drug of Abuse (DOA) Testing Consumption by Type (2013-2018) (K Units)
Table APAC At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type (2013-2018)
Figure APAC At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type in 2017
Table APAC At-Home Drug of Abuse (DOA) Testing Consumption by Application (2013-2018) (K Units)
Table APAC At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application (2013-2018)
Figure APAC At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application in 2017
Figure China At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure China At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Japan At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Japan At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Korea At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Korea At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure India At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure India At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Australia At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Australia At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Table Europe At-Home Drug of Abuse (DOA) Testing Consumption by Countries (2013-2018) (K Units)
Table Europe At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Countries (2013-2018)
Figure Europe At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Countries in 2017
Table Europe At-Home Drug of Abuse (DOA) Testing Value by Countries (2013-2018) ($ Millions)
Table Europe At-Home Drug of Abuse (DOA) Testing Value Market Share by Countries (2013-2018)
Figure Europe At-Home Drug of Abuse (DOA) Testing Value Market Share by Countries in 2017
Table Europe At-Home Drug of Abuse (DOA) Testing Consumption by Type (2013-2018) (K Units)
Table Europe At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type (2013-2018)
Figure Europe At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type in 2017
Table Europe At-Home Drug of Abuse (DOA) Testing Consumption by Application (2013-2018) (K Units)
Table Europe At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application (2013-2018)
Figure Europe At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application in 2017
Figure Germany At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Germany At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure France At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure France At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure UK At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure UK At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Italy At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Italy At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Russia At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Russia At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Spain At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Spain At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Countries in 2017
Table Middle East & Africa At-Home Drug of Abuse (DOA) Testing Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa At-Home Drug of Abuse (DOA) Testing Value Market Share by Countries (2013-2018)
Figure Middle East & Africa At-Home Drug of Abuse (DOA) Testing Value Market Share by Countries in 2017
Table Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type in 2017
Table Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application in 2017
Figure Egypt At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Egypt At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure South Africa At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure South Africa At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Israel At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Israel At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Turkey At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Turkey At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure GCC Countries At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure GCC Countries At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Table At-Home Drug of Abuse (DOA) Testing Distributors List
Table At-Home Drug of Abuse (DOA) Testing Customer List
Figure Global At-Home Drug of Abuse (DOA) Testing Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global At-Home Drug of Abuse (DOA) Testing Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Forecast by Countries (2018-2023) (K Units)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Market Forecast by Regions
Table Global At-Home Drug of Abuse (DOA) Testing Value Forecast by Countries (2018-2023) ($ Millions)
Table Global At-Home Drug of Abuse (DOA) Testing Value Market Share Forecast by Regions
Figure Americas At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Americas At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure APAC At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure APAC At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Europe At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Europe At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Middle East & Africa At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure United States At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure United States At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Canada At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Canada At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Mexico At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Mexico At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Brazil At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Brazil At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure China At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure China At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Japan At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Japan At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Korea At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Korea At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Southeast Asia At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Southeast Asia At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure India At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure India At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Australia At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Australia At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Germany At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Germany At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure France At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure France At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure UK At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure UK At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Italy At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Italy At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Russia At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Russia At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Spain At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Spain At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Egypt At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Egypt At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure South Africa At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure South Africa At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Israel At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Israel At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Turkey At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Turkey At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure GCC Countries At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure GCC Countries At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Forecast by Type (2018-2023) (K Units)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share Forecast by Type (2018-2023)
Table Global At-Home Drug of Abuse (DOA) Testing Value Forecast by Type (2018-2023) ($ Millions)
Table Global At-Home Drug of Abuse (DOA) Testing Value Market Share Forecast by Type (2018-2023)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Forecast by Application (2018-2023) (K Units)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share Forecast by Application (2018-2023)
Table Global At-Home Drug of Abuse (DOA) Testing Value Forecast by Application (2018-2023) ($ Millions)
Table Global At-Home Drug of Abuse (DOA) Testing Value Market Share Forecast by Application (2018-2023)
Table UCP Biosciences Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table UCP Biosciences Inc. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure UCP Biosciences Inc. At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
Table Orient New Life Medical Co. Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Orient New Life Medical Co. Ltd. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Orient New Life Medical Co. Ltd. At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
Table Express Diagnostics Int’l Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Express Diagnostics Int’l Inc. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Express Diagnostics Int’l Inc. At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
Table Assure Tech (Hangzhou) Co. Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Assure Tech (Hangzhou) Co. Ltd. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Assure Tech (Hangzhou) Co. Ltd. At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
Table Psychemedics Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
Table Confirm BioSciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
Table Phamatech Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Phamatech Inc. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Phamatech Inc. At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
Table Home Health (U.K.) Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
Table Quest Products Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Quest Products Inc. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Quest Products Inc. At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
Figure Picture of At-Home Drug of Abuse (DOA) Testing
Table Product Specifications of At-Home Drug of Abuse (DOA) Testing
Figure At-Home Drug of Abuse (DOA) Testing Report Years Considered
Figure Market Research Methodology
Figure Global At-Home Drug of Abuse (DOA) Testing Consumption Growth Rate 2013-2023 (K Units)
Figure Global At-Home Drug of Abuse (DOA) Testing Value Growth Rate 2013-2023 ($ Millions)
Table At-Home Drug of Abuse (DOA) Testing Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Test Cups
Table Major Players of Test Cups
Figure Product Picture of Test Dip Cards
Table Major Players of Test Dip Cards
Figure Product Picture of Test Strips
Table Major Players of Test Strips
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2013-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type (2013-2018)
Figure Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type (2013-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Revenue by Type (2013-2018) ($ million)
Table Global At-Home Drug of Abuse (DOA) Testing Value Market Share by Type (2013-2018) ($ Millions)
Figure Global At-Home Drug of Abuse (DOA) Testing Value Market Share by Type (2013-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Sale Price by Type (2013-2018)
Figure At-Home Drug of Abuse (DOA) Testing Consumed in Urine
Figure Global At-Home Drug of Abuse (DOA) Testing Market: Urine (2013-2018) (K Units)
Figure Global At-Home Drug of Abuse (DOA) Testing Market: Urine (2013-2018) ($ Millions)
Figure Global Urine YoY Growth ($ Millions)
Figure At-Home Drug of Abuse (DOA) Testing Consumed in Saliva
Figure Global At-Home Drug of Abuse (DOA) Testing Market: Saliva (2013-2018) (K Units)
Figure Global At-Home Drug of Abuse (DOA) Testing Market: Saliva (2013-2018) ($ Millions)
Figure Global Saliva YoY Growth ($ Millions)
Figure At-Home Drug of Abuse (DOA) Testing Consumed in Hair
Figure Global At-Home Drug of Abuse (DOA) Testing Market: Hair (2013-2018) (K Units)
Figure Global At-Home Drug of Abuse (DOA) Testing Market: Hair (2013-2018) ($ Millions)
Figure Global Hair YoY Growth ($ Millions)
Figure At-Home Drug of Abuse (DOA) Testing Consumed in Others
Figure Global At-Home Drug of Abuse (DOA) Testing Market: Others (2013-2018) (K Units)
Figure Global At-Home Drug of Abuse (DOA) Testing Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application (2013-2018)
Figure Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application (2013-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Value by Application (2013-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Value Market Share by Application (2013-2018)
Figure Global At-Home Drug of Abuse (DOA) Testing Value Market Share by Application (2013-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Sale Price by Application (2013-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Sales by Players (2016-2018) (K Units)
Table Global At-Home Drug of Abuse (DOA) Testing Sales Market Share by Players (2016-2018)
Figure Global At-Home Drug of Abuse (DOA) Testing Sales Market Share by Players in 2016
Figure Global At-Home Drug of Abuse (DOA) Testing Sales Market Share by Players in 2017
Table Global At-Home Drug of Abuse (DOA) Testing Revenue by Players (2016-2018) ($ Millions)
Table Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players (2016-2018)
Figure Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players in 2016
Figure Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players in 2017
Table Global At-Home Drug of Abuse (DOA) Testing Sale Price by Players (2016-2018)
Figure Global At-Home Drug of Abuse (DOA) Testing Sale Price by Players in 2017
Table Global At-Home Drug of Abuse (DOA) Testing Manufacturing Base Distribution and Sales Area by Players
Table Players At-Home Drug of Abuse (DOA) Testing Products Offered
Table At-Home Drug of Abuse (DOA) Testing Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption by Regions 2013-2018 (K Units)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Regions 2013-2018
Figure Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Regions 2013-2018
Table Global At-Home Drug of Abuse (DOA) Testing Value by Regions 2013-2018 ($ Millions)
Table Global At-Home Drug of Abuse (DOA) Testing Value Market Share by Regions 2013-2018
Figure Global At-Home Drug of Abuse (DOA) Testing Value Market Share by Regions 2013-2018
Figure Americas At-Home Drug of Abuse (DOA) Testing Consumption 2013-2018 (K Units)
Figure Americas At-Home Drug of Abuse (DOA) Testing Value 2013-2018 ($ Millions)
Figure APAC At-Home Drug of Abuse (DOA) Testing Consumption 2013-2018 (K Units)
Figure APAC At-Home Drug of Abuse (DOA) Testing Value 2013-2018 ($ Millions)
Figure Europe At-Home Drug of Abuse (DOA) Testing Consumption 2013-2018 (K Units)
Figure Europe At-Home Drug of Abuse (DOA) Testing Value 2013-2018 ($ Millions)
Figure Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption 2013-2018 (K Units)
Figure Middle East & Africa At-Home Drug of Abuse (DOA) Testing Value 2013-2018 ($ Millions)
Table Americas At-Home Drug of Abuse (DOA) Testing Consumption by Countries (2013-2018) (K Units)
Table Americas At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Countries (2013-2018)
Figure Americas At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Countries in 2017
Table Americas At-Home Drug of Abuse (DOA) Testing Value by Countries (2013-2018) ($ Millions)
Table Americas At-Home Drug of Abuse (DOA) Testing Value Market Share by Countries (2013-2018)
Figure Americas At-Home Drug of Abuse (DOA) Testing Value Market Share by Countries in 2017
Table Americas At-Home Drug of Abuse (DOA) Testing Consumption by Type (2013-2018) (K Units)
Table Americas At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type (2013-2018)
Figure Americas At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type in 2017
Table Americas At-Home Drug of Abuse (DOA) Testing Consumption by Application (2013-2018) (K Units)
Table Americas At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application (2013-2018)
Figure Americas At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application in 2017
Figure United States At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure United States At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Canada At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Canada At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Mexico At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Mexico At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Table APAC At-Home Drug of Abuse (DOA) Testing Consumption by Countries (2013-2018) (K Units)
Table APAC At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Countries (2013-2018)
Figure APAC At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Countries in 2017
Table APAC At-Home Drug of Abuse (DOA) Testing Value by Countries (2013-2018) ($ Millions)
Table APAC At-Home Drug of Abuse (DOA) Testing Value Market Share by Countries (2013-2018)
Figure APAC At-Home Drug of Abuse (DOA) Testing Value Market Share by Countries in 2017
Table APAC At-Home Drug of Abuse (DOA) Testing Consumption by Type (2013-2018) (K Units)
Table APAC At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type (2013-2018)
Figure APAC At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type in 2017
Table APAC At-Home Drug of Abuse (DOA) Testing Consumption by Application (2013-2018) (K Units)
Table APAC At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application (2013-2018)
Figure APAC At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application in 2017
Figure China At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure China At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Japan At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Japan At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Korea At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Korea At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure India At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure India At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Australia At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Australia At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Table Europe At-Home Drug of Abuse (DOA) Testing Consumption by Countries (2013-2018) (K Units)
Table Europe At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Countries (2013-2018)
Figure Europe At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Countries in 2017
Table Europe At-Home Drug of Abuse (DOA) Testing Value by Countries (2013-2018) ($ Millions)
Table Europe At-Home Drug of Abuse (DOA) Testing Value Market Share by Countries (2013-2018)
Figure Europe At-Home Drug of Abuse (DOA) Testing Value Market Share by Countries in 2017
Table Europe At-Home Drug of Abuse (DOA) Testing Consumption by Type (2013-2018) (K Units)
Table Europe At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type (2013-2018)
Figure Europe At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type in 2017
Table Europe At-Home Drug of Abuse (DOA) Testing Consumption by Application (2013-2018) (K Units)
Table Europe At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application (2013-2018)
Figure Europe At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application in 2017
Figure Germany At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Germany At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure France At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure France At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure UK At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure UK At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Italy At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Italy At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Russia At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Russia At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Spain At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Spain At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Countries in 2017
Table Middle East & Africa At-Home Drug of Abuse (DOA) Testing Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa At-Home Drug of Abuse (DOA) Testing Value Market Share by Countries (2013-2018)
Figure Middle East & Africa At-Home Drug of Abuse (DOA) Testing Value Market Share by Countries in 2017
Table Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Type in 2017
Table Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption Market Share by Application in 2017
Figure Egypt At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Egypt At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure South Africa At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure South Africa At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Israel At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Israel At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure Turkey At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure Turkey At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Figure GCC Countries At-Home Drug of Abuse (DOA) Testing Consumption Growth 2013-2018 (K Units)
Figure GCC Countries At-Home Drug of Abuse (DOA) Testing Value Growth 2013-2018 ($ Millions)
Table At-Home Drug of Abuse (DOA) Testing Distributors List
Table At-Home Drug of Abuse (DOA) Testing Customer List
Figure Global At-Home Drug of Abuse (DOA) Testing Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global At-Home Drug of Abuse (DOA) Testing Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Forecast by Countries (2018-2023) (K Units)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Market Forecast by Regions
Table Global At-Home Drug of Abuse (DOA) Testing Value Forecast by Countries (2018-2023) ($ Millions)
Table Global At-Home Drug of Abuse (DOA) Testing Value Market Share Forecast by Regions
Figure Americas At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Americas At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure APAC At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure APAC At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Europe At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Europe At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Middle East & Africa At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Middle East & Africa At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure United States At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure United States At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Canada At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Canada At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Mexico At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Mexico At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Brazil At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Brazil At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure China At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure China At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Japan At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Japan At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Korea At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Korea At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Southeast Asia At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Southeast Asia At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure India At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure India At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Australia At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Australia At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Germany At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Germany At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure France At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure France At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure UK At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure UK At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Italy At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Italy At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Russia At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Russia At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Spain At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Spain At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Egypt At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Egypt At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure South Africa At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure South Africa At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Israel At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Israel At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure Turkey At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure Turkey At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Figure GCC Countries At-Home Drug of Abuse (DOA) Testing Consumption 2018-2023 (K Units)
Figure GCC Countries At-Home Drug of Abuse (DOA) Testing Value 2018-2023 ($ Millions)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Forecast by Type (2018-2023) (K Units)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share Forecast by Type (2018-2023)
Table Global At-Home Drug of Abuse (DOA) Testing Value Forecast by Type (2018-2023) ($ Millions)
Table Global At-Home Drug of Abuse (DOA) Testing Value Market Share Forecast by Type (2018-2023)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Forecast by Application (2018-2023) (K Units)
Table Global At-Home Drug of Abuse (DOA) Testing Consumption Market Share Forecast by Application (2018-2023)
Table Global At-Home Drug of Abuse (DOA) Testing Value Forecast by Application (2018-2023) ($ Millions)
Table Global At-Home Drug of Abuse (DOA) Testing Value Market Share Forecast by Application (2018-2023)
Table UCP Biosciences Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table UCP Biosciences Inc. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure UCP Biosciences Inc. At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
Table Orient New Life Medical Co. Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Orient New Life Medical Co. Ltd. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Orient New Life Medical Co. Ltd. At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
Table Express Diagnostics Int’l Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Express Diagnostics Int’l Inc. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Express Diagnostics Int’l Inc. At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
Table Assure Tech (Hangzhou) Co. Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Assure Tech (Hangzhou) Co. Ltd. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Assure Tech (Hangzhou) Co. Ltd. At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
Table Psychemedics Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
Table Confirm BioSciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
Table Phamatech Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Phamatech Inc. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Phamatech Inc. At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
Table Home Health (U.K.) Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
Table Quest Products Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Quest Products Inc. At-Home Drug of Abuse (DOA) Testing Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Quest Products Inc. At-Home Drug of Abuse (DOA) Testing Market Share (2016-2018)
